1. Home
  2. CAVA vs RDY Comparison

CAVA vs RDY Comparison

Compare CAVA & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CAVA Group Inc.

CAVA

CAVA Group Inc.

HOLD

Current Price

$51.87

Market Cap

10.6B

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$12.28

Market Cap

9.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAVA
RDY
Founded
2006
1984
Country
United States
India
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6B
9.9B
IPO Year
2023
2001

Fundamental Metrics

Financial Performance
Metric
CAVA
RDY
Price
$51.87
$12.28
Analyst Decision
Buy
Strong Buy
Analyst Count
23
1
Target Price
★ $91.00
$16.90
AVG Volume (30 Days)
★ 3.2M
2.3M
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
★ 0.52%
EPS Growth
N/A
★ N/A
EPS
★ 0.39
N/A
Revenue
★ $1,179,664,000.00
N/A
Revenue This Year
$25.71
$7.72
Revenue Next Year
$20.57
$3.50
P/E Ratio
$137.21
★ $18.67
Revenue Growth
★ 22.41
N/A
52 Week Low
$43.41
$11.36
52 Week High
$98.79
$15.67

Technical Indicators

Market Signals
Indicator
CAVA
RDY
Relative Strength Index (RSI) 33.86 53.46
Support Level $49.68 $12.09
Resistance Level $74.08 $12.48
Average True Range (ATR) 2.21 0.20
MACD 0.09 0.07
Stochastic Oscillator 19.49 64.05

Price Performance

Historical Comparison
CAVA
RDY

About CAVA CAVA Group Inc.

Cava Group Inc owns and operates a chain of restaurants. It operates a Mediterranean-inspired fast-casual restaurant brand offering menu items. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: i) CAVA: It includes the operations of all company-owned CAVA restaurants, and ii) CAVA Foods: It includes the production of dips, spreads, and certain dressing bases used in CAVA restaurants as well as sales from the Company's consumer packaged goods business. The company generates the majority of its revenue from the CAVA segment.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: